Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - RESEARCH & DEVELOPMENT
Research & Development TRVI - Trevi Therapeutics, Inc.
23.7 M
LAST VALUE
1.51%
2 YEAR CAGR
10.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR